NCT00416195View on ClinicalTrials.gov

Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures

PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

March 31, 2008

Conditions
Epilepsy
Interventions
DRUG

E2007

DRUG

Placebo

Trial Locations (2)

LV-1002

P. Stradina Clinical University Hospital, Riga

LV-1038

Hospital Gailezers, Riga

All Listed Sponsors
collaborator

Eisai Limited

INDUSTRY

lead

Eisai Co., Ltd.

INDUSTRY

NCT00416195 - Exploring the Safety And Tolerability of Doses of E2007 up to a Maximum of 12 mg In Patients With Refractory Partial Seizures | Biotech Hunter | Biotech Hunter